CERo’s technology works by grafting onto patients’ own T-cells a receptor that binds to a naturally occurring human antigen that is upregulated in cancer cells.

Ring-shaped extrachromosomal DNA is implicated in many cancers. Rachel Brazil talks to the scientists trying to uncover their ...

DelveInsight’s Non-Hodgkin Lymphoma pipeline report depicts a robust space with 200+ Non-Hodgkin Lymphoma companies working ...

As the fight against HIV evolves, our high-quality antigens empower researchers, vaccine developers, and diagnostic ...

Algorithms such as XGBoost, SVMs, and random forests are being trained to estimate drug concentration-time curves, protein-binding affinities, and potential adverse interactions - all from ...

The pharma is working on CD19 NEX-T, an investigational CAR T therapy designed to seek out the cell surface protein CD19, which is highly expressed ... enables the controlled binding of the CAR ...

Scientists have for the first time looked deep into the protein structure that may determine our vision - and discovered that ...

Oncolytic adenovirus was engineered for the forced ectopic delivery of peptide-MHC ligand of T cell receptors (TCRs) to ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.